IMPLANTABLE WIRELESS SOUND SENSOR

• US 20070208390A1
• Filed: 03/01/2006
• Published: 09/06/2007
• Est. Priority Date: 03/01/2006
• Status: Abandoned Application

• Current Assignee: Cardiac Pacemakers Incorporated (Boston Scientific Corporation)
• Original Assignee: Cardiac Pacemakers Incorporated (Boston Scientific Corporation)
• Inventors: Chavan, Abhi, Maile, Keith, Von Arx, Jeffrey
• Application Number:
  US11/276,466
• Publication Number:
  US 20070208390A1
• Time in Patent Office: Days
• US Class Current: 607/32
• CPC Class Codes: A61N 1/36514 controlled by a physiological quantity other than heart potential, e.g. blood pressure controlled by two or more physical parameters A61N1/36585
• CPC Class Codes: A61N 1/36528 the parameter being measured by means of ultrasound
• CPC Class Codes: A61N 1/36535 controlled by body position or posture
• CPC Class Codes: A61N 1/36542 controlled by body motion, e.g. acceleration
• CPC Class Codes: A61N 1/36578 controlled by mechanical motion of the heart wall, e.g. measured by an accelerometer or microphone
• CPC Class Codes: A61N 1/37205 Microstimulators, e.g. implantable through a cannula
• CPC Class Codes: A61N 1/37288 Communication to several implantable medical devices within one patient

Abstract

An apparatus and method is presented for an implanted sound sensor wirelessly communicating with an implantable medical device, or with an external monitoring device. The second sensor may be located inside a blood vessel anchored by an expandable stent like device, and may be drug coated. The sound sensor may be a solid-state microphone having a unidirectional characteristic and may be aimed at a selected portion of the heart, lung, or other location. There may be a network of sound sensors forming a local area network with the implantable medical device. The information from the sound sensor may be analyzed, filtered, transformed, compared to a standard and stored in the implantable device, or it may be passed on to an external location. The results of the analysis may be use to initiate a closed-loop treatment by the implantable medical device, such as cardiac pacing or defibrillation.

Claims

1. A system, comprising:

an implantable housing including a memory circuit and an electronic communication circuit configured to communicate from within a body to an external location; and

a separate implantable biological or physiological sound detector communicatively coupled to the implantable housing when the sound detector and the implantable housing are both implanted in a body.

2. The system of claim 1, wherein the implantable housing comprises at least one of a cardiac pacer, a cardiac defibrillator, a cardiac resynchronization device, a diagnostic analysis circuit, a memory circuit and a closed-loop controller.

3. The system of claim 1, wherein the sound detector includes a transceiver to communicate with the implantable housing using at least one of a modulated electromagnetic signal, a modulated radio frequency signal, a modulated acoustic signal, a modulated ultrasonic signal, a modulated e-field, an electrical wire, and an inductive coupling signal.

4. The system of claim 3, comprising a plurality of the sound detectors in communication with the implantable housing when the plurality of the sound detectors and the implantable housing are implanted within the body.

5. The system of claim 1, wherein the sound detector comprises a battery that is rechargeable by at least one of externally applied ultrasound and inductively-coupled power transmission.

6. The system of claim 1, comprising a biocompatible pod enclosing the sound detector.

7. The system of claim 6, wherein at least one of:

the wall includes a wall thickness of between 0.001 to 0.002 inches; and

the wall includes a wall thickness of between 0.011 to 0.012 inches and the wall further includes a diaphragm portion disposed near the sound detector having a thickness of between 0.001 to 0.002 inches.

8. The system of claim 6, wherein the pod has a shape that is selected from a cylinder, a can, a pill, a rectangular solid, a capsule and a tube.

9. The system of claim 8, wherein the pod has a major dimension and a minor dimension, the minor dimension being less than 2.0 mm.

10. The system of claim 9, wherein the pod is sized and shaped to permit the pod to be disposed inside a blood vessel.

11. The system of claim 6, wherein the pod includes an anchor, attached to the pod, to anchor the pod to a selected position inside the body.

12. The system of claim 11, wherein the anchor comprises one of an expandable stent-like mesh, and a self-expanding stent-like mesh.

13. The system of claim 10, wherein the anchor comprises a drug-coated stent-like mesh.

14. The system of claim 6, wherein the pod is sized and shaped to permit the pod to be disposed at a location selected from inside an esophagus, trachea, bronchus, lung, peritoneum, pericardium and an alimentary organ.

15. The system of claim 6, wherein the pod includes the sound detector, an ultrasonic communication device for communicating with the implantable housing, an acoustic impedance matching material, and a rechargeable battery.

16. The system of claim 15, wherein the acoustic impedance matching material is selected from a list including a silicone gel, a silicone liquid, a hydrocarbon fluid, a fluorocarbon fluid, and mixtures thereof, wherein the impedance matching material substantially completely fills a portion of the pod near the sound detector and has a viscosity selected to match a desired acoustic wavelength.

17. The system of claim 15, wherein the sound detector includes a directional acoustic wave detector to be aimed at a selected portion of the body, and the sound detector is configured to monitor at least one of heart sounds, mitral valve regurgitation, S3 heart sounds, lung sounds, rasps, rales, cough, and blood vessel sounds.

18. The system of claim 1, wherein the implantable housing comprises a signal processing circuit configured to perform at least one of:

a fast Fourier transform, a comparison of a later heart sound to an earlier heart sound, a comparison of a detected heart sound to a stored template heart sound.

19. The system of claim 1, wherein the sound detector comprises a microphone.

20. The system of claim 1, wherein the implantable housing comprises at least one of an accelerometer, a position detector, a temperature detector, and a closed-loop regulator to regulate a therapy at least partially in response to information in detected waves.

21. A system comprising:

an implantable housing including;

a cardiac function management circuit; and

an electronic communication circuit configured to perform two way communication via a modulated radio frequency carrier with an external device; and

a first ultrasonic communication circuit; and

an implantable biological sound detector, adapted to be located remote from the implantable housing, the sound detector comprising a second ultrasonic communication circuit for ultrasonic communication with the first ultrasonic communication circuit, the remote sound detector including an anchor to secure the remote sound detector at a desired location.

22. The system of claim 21, wherein the sound detector comprises a biocompatible covering having a diameter of less than 2 mm, the covering enclosing the sound detector, an ultrasonic transceiver, and a battery.

23. The system of claim 22, wherein the biocompatible covering comprises at least one of a titanium shell, a glass shell, and a plastic film, and wherein the biocompatible external covering includes at least one location having a high acoustic conductance.

24. The system of claim 23, wherein the sound detector includes a unidirectional microphone aimed at the location having a high acoustic conductance.

25. A method comprising:

detecting internal physiological acoustic waves using a first implantable medical device at a first location within a body; and

wirelessly communicating information obtained from the acoustic waves from the first implantable medical device at the first location to a separate second implantable medical device at a second location within the body.

26. The method of claim 25, comprising using the information for at least one of closed-loop delivering of therapy from the second implantable medical device and communicating the information to an external device.

27. The method of claim 25, comprising disposing the first implantable medical device in a blood vessel of the body, and disposing the second implantable medical device in a subcutaneous pectoral region of the body.

28. The method of claim 25, comprising disposing a directional microphone aimed at a selected one of a heart, a lung and a blood vessel.